Loading

Phenomics Health Inc

June 17, 2025
Company Presentation
AI and Digital Health
Phenomics Health™ is the first precision medicine company to personalize drug treatment by predicting the optimal medication and dose for each patient. We combine drug level measurement with tools to assess polypharmacy, drug-drug interactions, and adherence. Our CLIA-certified lab integrates data from pharmacometabolomics, long-read sequencing, polygenic risk scores, and clinical records from biobanks like the Michigan Genomics Initiative to power a proprietary Foundation Model. This model identifies patients at high risk due to complex medication regimens and comorbidities. Phenomics Health acts as a virtual second opinion for difficult cases—enhancing safety, reducing adverse events, and improving outcomes, while minimizing financial and legal risk. Our platform is also used in clinical trials for patient-trial matching, safety analytics, and AI-powered multi-omic insights for drug discovery.
Phenomics Health Inc
Company HQ City: Plymouth
Company HQ State: MI
Company HQ Country: United States
Year Founded: 2018
Lead Product in Development: Phenomics AI

CEO

Daniel Jasewicz

Development Phase of Lead Product

Other/Not Applicable

Number of Unlicensed Products Looking for Licensing

Multiple Products in Pharmacogenomics and Pharmacometabolomics

When you expect your next catalyst update?

Series B

What is your next catalyst (value inflection) update?

Q1 2026
Visit Website
Primary Speaker
Daniel Jasewicz
Daniel Jasewicz, MSc
CEO
Phenomics Health Inc
Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS